Nadja West - Apr 25, 2024 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Director
Signature
/s/ Raavi K. Deol, as attorney-in-fact for Nadja Y. West
Stock symbol
JNJ
Transactions as of
Apr 25, 2024
Transactions value $
$0
Form type
4
Date filed
4/29/2024, 05:06 PM
Previous filing
Jun 5, 2023
Next filing
May 10, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Deferred Share Units Award $0 +1.39K +37.37% $0.00 5.09K Apr 25, 2024 Common Stock 1.39K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).
F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.